Efficacy and Safety of the Shexiang Baoxin Pill for the Treatment of Coronary Artery Disease Not Amenable to Revascularisation: Study Protocol for a Randomised, Placebo-Controlled, Double-Blinded Trial

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2017-018052
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy